Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02) | PAR 16 382

Opportunity Information: Apply for PAR 16 382

The Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02) opportunity (PAR-16-382) is a National Institutes of Health (NIH) funding announcement from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). It is positioned as an entry step (a pre-application) for the NIAMS RISK program, which is aimed at sparking bold, unconventional work in areas that fall within the NIAMS mission, specifically here with an emphasis on musculoskeletal diseases. The overarching goal is to create space for ideas that challenge the status quo, especially projects built around surprising observations, imaginative hypotheses, and new conceptual frameworks that diverge from prevailing theories or standard practice.

A defining feature of this program is that it is explicitly designed for proposals that might struggle in traditional NIH review settings because they are viewed as too risky, too early, too controversial, or too unconventional. NIAMS is signaling that it wants investigators to take scientific chances when the potential payoff is high, even if preliminary data are limited or the idea does not align neatly with established consensus. In practical terms, the RISK initiative emphasizes innovation over incremental advances, encouraging applicants to pursue research directions that could reshape understanding or open entirely new avenues for diagnosing or treating musculoskeletal disease.

In terms of scope, the RISK initiative is intended to support disease-focused translational research, but only up to a clear boundary: it can support studies leading toward human application, but not first-in-human work. The related RISK R61/R33 funding opportunities that this pre-application points toward are also specifically not intended to support clinical trials. That means the program is geared toward preclinical or translational activities such as mechanistic studies, target validation, proof-of-concept work in relevant model systems, and other preparatory steps that could enable later clinical development, while stopping short of initiating human testing.

Organizational eligibility is broad and includes many common U.S.-based applicant types, such as state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations (including those other than federally recognized tribal governments); public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status; for-profit organizations (other than small businesses); and small businesses. The announcement also highlights additional categories of eligible applicants that NIH often encourages, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.

At the same time, the opportunity places firm limits on foreign participation. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply, and foreign components (as defined by the NIH Grants Policy Statement) are not allowed. In other words, applicants must be U.S.-based, and the project work cannot be structured to rely on foreign components under NIH definitions.

Administratively, this is a discretionary grant opportunity in the health funding category (CFDA 93.846). The original closing date listed for the pre-application was October 18, 2016, and the posting date (creation date) is August 1, 2016. The source data does not provide an award ceiling or expected number of awards, indicating those details were either not specified in the summary data or were addressed in the full announcement materials rather than this extract.

Overall, this opportunity is best understood as a pathway into NIAMS support for high-risk, high-reward musculoskeletal disease research that is translational in intent, preclinical in execution, and deliberately non-trial in structure. It is meant for investigators and organizations willing to advance ideas that may not yet be widely accepted or extensively validated, but that could meaningfully change how musculoskeletal diseases are understood and eventually treated.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.846.
• This funding opportunity was created on 2016-08-01.
• Applicants must submit their applications by 2016-10-18. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 16 382

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: